Screening for rheumatic diseases in the MS clinic: fulfilling the McDonald diagnostic criteria? by Rolinski, M, Nimmo, M, Traboulsee, A

Screening for rheumatic diseases in the MS clinic: fulfilling the diagnostic criteria? by Rolinski, M, Nimmo, M, Traboulsee, A

Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interf... by Bennett R, AL-Sabbagh A, Traboulsee A, Chang P, Li DKB

Get full text

Long-term follow up of interferon-beta-1b pivotal trial RRMS patients: design issues of a 16-year follow-up study by Ebers, G, Rice, G, Traboulsee, A, Kaskel, P, Wolf, C, Salazar-Grueso, E

Association of smoking with risk of multiple sclerosis: a population-based study. by Ramagopalan, S, Lee, J, Yee, I, Guimond, C, Traboulsee, A, Ebers, G, Sadovnick, A

Association of smoking with risk of multiple sclerosis: A population-based study by Ramagopalan, S, Lee, J, Yee, I, Guimond, C, Traboulsee, A, Ebers, G, Sadovnick, A

The final results of the interferon beta-1b 16-year long-term follow-up study by Ebers, G, Traboulsee, A, Langdon, D, Reder, A, Miltenburger, C, Wolf, C, Konieczny, A

The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes by Reder, A, Ebers, G, Goodin, D, Li, D, Traboulsee, A, Beckman, K, Konieczny, A

Multi-component relaxation reveals distinct patterns of white matter involvement in primary progressive multiple sclerosis and primary lateral sclerosis by Kolind, S, Seddigh, A, Sibtain, N, Deoni, S, Barker, G, Traboulsee, A, Williams, S, Turner, M, Brex, P

16-year long-term follow-up of interferon beta-1b treatment in patients with multiple sclerosis by Ebers, G, Rice, G, Wolf, C, Traboulsee, A, Langdon, D, Kaskel, P, Salazar-Grueso, E

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS. by Reder, A, Ebers, G, Traboulsee, A, Li, D, Langdon, D, Goodin, D, Bogumil, T, Beckmann, K, Konieczny, A

EDSS and MRI burden of disease predict cognitive status at 16 years: data from the long term follow-up study by Langdon, D, Reder, A, Ebers, G, Goodin, D, Traboulsee, A, Li, D, Beckmann, K, Konieczny, A, Grp, 1

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study. by Ebers, G, Reder, A, Traboulsee, A, Li, D, Langdon, D, Goodin, D, Wolf, C, Beckmann, K, Konieczny, A

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial. by Ebers, G, Traboulsee, A, Li, D, Langdon, D, Reder, A, Goodin, D, Bogumil, T, Beckmann, K, Wolf, C, Konieczny, A

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis by Goodin, D, Traboulsee, A, Knappertz, V, Reder, A, Li, D, Langdon, D, Wolf, C, Beckmann, K, Konieczny, A, Ebers, G

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis. by Goodin, D, Traboulsee, A, Knappertz, V, Reder, A, Li, D, Langdon, D, Wolf, C, Beckmann, K, Konieczny, A, Ebers, G

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis by Goodin, D, Traboulsee, A, Knappertz, V, Knappertz, V, Knappertz, V, Reder, A, Li, D, Langdon, D, Wolf, C, Beckmann, K, Konieczny, A, Ebers, G

Treatment of Neuromyelitis Optica: Review and Recommendations. by Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, de Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D

Treatment of neuromyelitis optica: Review and recommendations by Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Isabel Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, De Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D, Guthy Jackson Charitable Foundation Clinical Consortium and Biorepository